SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-18-038055
Filing Date
2018-06-15
Accepted
2018-06-15 16:27:26
Documents
2
Period of Report
2018-05-31

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3902
2 POA DOCUMENT poa.txt EX-24.4_796819 4540
  Complete submission text file 0001209191-18-038055.txt   9904
Mailing Address 1035 O'BRIEN DRIVE MENLO PARK CA 94025
Business Address 1035 O'BRIEN DRIVE MENLO PARK CA 94025 650-272-6269
Adverum Biotechnologies, Inc. (Issuer) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address ONE SANSOME STREET SUITE 3630 SAN FRANCISCO CA 94104
Business Address
Woiwode Thomas (Reporting) CIK: 0001619294 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36579 | Film No.: 18902525